This is the first in a multi-part series in which we unpack our seven event categories and how they intersect with the use of psychedelics. First up, NATURE CONNECTION and how psychedelics may open up a door to a deeper relationship with the earth - and ourselves.

Roberta Jean is a critically acclaimed choreographer whose most recent performance, Ways of Being (Thursday, 9th, and Friday, 10th Nov, at Sadler Wells Lilian Baylis Studio, London) incorporates suffering related to premenstrual disorder (PMDD) and healing through psychedelics. In this piece we explore the evidence of microdosing to soothe this painful and life-disrupting disorder.

In psychedelic research today, people with a personal or family history of psychotic disorders can't participate in clinical trials, sadly excluding many who may need treatment most. But several researchers are investigating the potential of psychedelics to treat disorders like bipolar and schizophrenia. We investigate, what's the real relationship between psychedelics and psychosis?

A research group at University College London (UCL) aims to understand how DMT's psychological benefits could relate to brain activity changes and potential treatment of alcoholism and more.

Martha Allitt shares her reflections on Parliament Square protest to discuss UK drug policy reform. The event was the seventh mass lobby organised by Anyone's Child - a network of families with lives devastated by the harms of drug prohibition.

Martha Allitt of The Psychedelic Society team shares her recent personal experience with ayahuasca and the way it helped her reframe her relationship to her childhood eating disorder.

In the psychedelic sphere, tensions between medicalisation, indigenous tradition, business, and advocacy are on the rise. As psychedelic mainstreaming rapidly unfolds, a move toward greater holisticism is key. In this post, we’ll look at the work of Gabriel Amezcua’s incredible work on holisticism and how these elements interact.

Mainstream media headlines position psychedelics as yet another promise for a 'one-shoe-size-fits-all' miracle drug. We take a critical look at this - and highlight an alternative model.